MedTrace Logo

Nutritional Supplements & Complementary/Alternative Medicine by Prostate & Breast Cancer Patients

NCT01823549 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 109

Last updated 2025-12-29

No results posted yet for this study

Summary

This study was a survey to determine the frequency of Complementary and Alternative Medicine (CAM) use in patients recently diagnosed with breast or prostate cancer who were starting radiation therapy. The survey was repeated at three time points to assess changes in CAM use over time.

Conditions

Interventions

OTHER

questionnaire administration

Ancillary studies

Sponsors & Collaborators

  • National Center for Complementary and Integrative Health (NCCIH)

    collaborator NIH

  • Ohio State University Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Steven Clinton, MD · Ohio State University Comprehensive Cancer Center

Eligibility

Min Age
21 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-12-11
Primary Completion
2014-09-30
Completion
2024-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01823549 on ClinicalTrials.gov